23.11.2014 Views

epr-method (2003) - IAEA Publications - International Atomic Energy ...

epr-method (2003) - IAEA Publications - International Atomic Energy ...

epr-method (2003) - IAEA Publications - International Atomic Energy ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

BENCHMARKS FOR INHALATION<br />

AI.5 Selection of proper D 2 values requires knowledge of the possible deterministic effects of<br />

internally deposited radionuclides. In contrast to deterministic effects from external radiation<br />

sources, there is very little information available on deterministic effects in human subjects from<br />

intake of radionuclides. A meeting of consultants was held to review the use of data on<br />

deterministic effects in laboratory animals to independently verify, in benchmark calculations,<br />

some of the D 2 values calculated. Models were used for deterministic health effects that were based<br />

on effects seen in life-span studies in dogs and rats [56,57]. The consultants focused on radiation<br />

pneumonitis/pulmonary fibrosis as the deterministic effect of interest for inhaled radionuclides<br />

because it would be the most likely cause of a permanent injury that decreases in the quality of life.<br />

Benchmark calculations were made for a number of r<strong>epr</strong>esentative radionuclides using basic<br />

principles from these models and doses calculated to the alveolar-interstitial (AI) region of the<br />

lung. The calculations estimated, assuming an intake faction of 10 -4 , the activity (TBq) that would<br />

result in an approximate threshold (5%) for morbidity from radiation pneumonitis/pulmonary<br />

fibrosis. Table AI-II compares these benchmark D 2 values with the D 2 values from Table A8-I.<br />

Generally speaking, there is good agreement between the two sets of D 2 values for alpha- and beta,<br />

gamma-emitting radionuclides.<br />

AI.6 A second set of calculations examined whether the criterion of 6 Gy to the lung in 2 days is<br />

an appropriate way to consider the chronic irradiation patterns for various beta, gamma-emitting<br />

radionuclides in the AI region. This was needed because of the broad range of effective retention<br />

and physical half-lives that might be involved. The consultants looked at several long-lived beta,<br />

gamma-emitting radionuclides. A different dose criterion, a cumulative absorbed dose of 75 Gy to<br />

the AI region in 1 year, was considered because it could lead to an approximate 5% morbidity level<br />

from radiation pneumonitis/pulmonary fibrosis. Table AI-III gives the results of these benchmark<br />

D 2 values compared with the Table A8-I values. Again, the two sets of numbers agree within<br />

factors of 2 or 3.<br />

AI.7 These benchmark calculations indicate that the Table A8-I values that have been examined<br />

are consistent within factors of 1 to 5 of values derived from the best currently available models on<br />

deterministic health effects in the lung. In most cases the D 2 values in Table A8-I appear to be<br />

slightly conservative.<br />

TABLE AI-II. COMPARISON OF TABLE A8-I D 2 VALUES WITH VALUES<br />

CALCULATED FROM MODELS FOR RADIATION PNEUMONITIS/PULMONARY<br />

FIBROSIS (AI, TYPE S).<br />

Nuclide Table A8-I Benchmark<br />

Beta, Gamma Emitters<br />

Sr-90 1 4.7<br />

Ce-144 9 63<br />

Cs-134 30 30<br />

Co-60 30 25<br />

Alpha Emitters<br />

Pu-238 0.06 0.08<br />

Pu-239 0.06 0.08<br />

Pu-240 0.06 0.08<br />

Am-241 0.06 0.08<br />

264

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!